{
    "answer": "Cytokine blockade therapies entering the clinic, and the addition of CD30 ligand targeting to existing cytokine (IL-2) therapy regimens",
    "ground_truth": "'Experts Forecast Cancer Research and Treatment Advances in 2025'",
    "rewards": [
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 4,
    "search count": 3,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        796,
        1047,
        2380,
        3865
    ]
}